Quality assurance of dysphagia-optimised intensity modulated radiotherapy treatment planning for head and neck cancer

Abstract

This study aimed to assess the impact of the margin applied to the clinical target volume, to create the planning target volume, on plan quality of a novel dysphagia-optimised intensity modulated radiotherapy technique developed within a head and neck cancer multicentre randomised controlled trial. Protocol compliant plans were used for a single benchmark planning case.Larger margins were associated with higher doses to adjacent organs at risk, particularly the inferior pharyngeal constrictor muscle, but coincided with some improved low dose target coverage. A 3 mm margin is recommended for this technique if local practices allow.

Keywords

• Intensity modulated radiotherapy (IMRT)
• Volumetric arc therapy (VMAT)
• Head and neck cancer
• Dysphagia
• Randomised controlled trial
• Quality assurance